13.55Open13.55Pre Close0 Volume2 Open Interest92.00Strike Price0.00Turnover0.00%IV0.75%PremiumMay 9, 2025Expiry Date12.96Intrinsic Value100Multiplier3DDays to Expiry0.59Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma6.10Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Merck & Co Stock Discussion
For the revenue consensus estimate, analysts anticipate revenue around $15.48 billion, which would be a slight decrease of about 1.9% year-over-year.
Wall Street expects Merck to report EPS of approximately $2.16. This would r...
Landmark Trial: Merck's New PAH Drug Shows Stunning 76% Reduction in Life-Threatening Events
No comment yet